Literature DB >> 2852376

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol.

E L Gardner1, W Paredes, D Smith, A Donner, C Milling, D Cohen, D Morrison.   

Abstract

The present experiment explored whether delta 9-tetrahydrocannabinol (delta 9-THC), the psychoactive ingredient in marijuana, shares with other drugs of abuse the ability to facilitate brain stimulation reward acutely, as measured by electrical intracranial self-stimulation (ICSS). Laboratory rats were implanted with stimulation electrodes in the medial forebrain bundle, and trained to stable performance on a self-titrating threshold ICSS paradigm. delta 9-THC, at a dose believed pharmacologically relevant to moderate human use of marijuana, acutely lowered ICSS thresholds, suggesting that marijuana acts on similar CNS hedonic systems to most other drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852376     DOI: 10.1007/bf02431546

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Experimental drug self-administration: generality across species and type of drug.

Authors:  R R Griffiths; G E Bigelow; I Liebson
Journal:  NIDA Res Monogr       Date:  1978-07

2.  Oral delta9-tetrahydrocannabinol toxicity in rats treated for periods up to six months.

Authors:  H Rosendrantz; R A Sprague; R W Fleischman; C Braude
Journal:  Toxicol Appl Pharmacol       Date:  1975-05       Impact factor: 4.219

3.  Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria.

Authors:  C Kornetsky
Journal:  NIDA Res Monogr       Date:  1985

Review 4.  Action of drugs of abuse on brain reward systems.

Authors:  R A Wise
Journal:  Pharmacol Biochem Behav       Date:  1980       Impact factor: 3.533

5.  Nigral transplants reinnervating the dopamine-depleted neostriatum can sustain intracranial self-stimulation.

Authors:  P J Fray; S B Dunnett; S D Iversen; A Björklund; U Stenevi
Journal:  Science       Date:  1983-01-28       Impact factor: 47.728

Review 6.  Brain substrates for reinforcement and drug self-administration.

Authors:  R A Wise; M A Bozarth
Journal:  Prog Neuropsychopharmacol       Date:  1981

7.  Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: a moveable electrode mapping study.

Authors:  D Corbett; R A Wise
Journal:  Brain Res       Date:  1980-03-03       Impact factor: 3.252

8.  Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity.

Authors:  T F Seeger; E L Gardner
Journal:  Brain Res       Date:  1979-10-12       Impact factor: 3.252

9.  The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study.

Authors:  J M Ng Cheong Ton; G A Gerhardt; M Friedemann; A M Etgen; G M Rose; N S Sharpless; E L Gardner
Journal:  Brain Res       Date:  1988-06-07       Impact factor: 3.252

10.  Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.

Authors:  C Spyraki; H C Fibiger; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more
  51 in total

1.  Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.

Authors:  Jason M Wiebelhaus; Travis W Grim; Robert A Owens; Matthew F Lazenka; Laura J Sim-Selley; Rehab A Abdullah; Micah J Niphakis; Robert E Vann; Benjamin F Cravatt; Jenny L Wiley; S Stevens Negus; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2014-11-14       Impact factor: 4.030

Review 2.  Animal models of cannabinoid reward.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward.

Authors:  David J Rademacher; Cecilia J Hillard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-12-28       Impact factor: 5.067

Review 4.  Looking for the role of cannabinoid receptor heteromers in striatal function.

Authors:  Sergi Ferré; Steven R Goldberg; Carme Lluis; Rafael Franco
Journal:  Neuropharmacology       Date:  2008-07-19       Impact factor: 5.250

Review 5.  The endocannabinoid system in brain reward processes.

Authors:  M Solinas; S R Goldberg; D Piomelli
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

6.  The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.

Authors:  L J Herberg; I C Rose
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.

Authors:  E L Gardner; L S Walker; W Paredes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.

Authors:  M Sabrina Spano; Liana Fattore; Gregorio Cossu; Serena Deiana; Paola Fadda; Walter Fratta
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

9.  delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens.

Authors:  A Bonnin; J J Fernández-Ruiz; M Martín; F Rodríguez de Fonseca; M L Hernández; J A Ramos
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 10.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.